Ladenburg Thalmann Financial Services’s GALENA BIOPHARMA INC COM RXII Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-30,125
| Closed | -$11K | – | 5126 |
|
|
2016
Q3 | $11K | Buy |
30,125
+1,250
| +4% | +$456 | ﹤0.01% | 3791 |
|
|
2016
Q2 | $13K | Sell |
28,875
-119,000
| -80% | -$53.6K | ﹤0.01% | 3641 |
|
|
2016
Q1 | $201K | Sell |
147,875
-5,500
| -4% | -$7.48K | ﹤0.01% | 1608 |
|
|
2015
Q4 | $225K | Sell |
153,375
-994
| -0.6% | -$1.46K | ﹤0.01% | 1503 |
|
|
2015
Q3 | $244K | Buy |
154,369
+794
| +0.5% | +$1.25K | 0.01% | 1350 |
|
|
2015
Q2 | $261K | Buy |
153,575
+12,000
| +8% | +$20.4K | ﹤0.01% | 1414 |
|
|
2015
Q1 | $197K | Sell |
141,575
-42
| -0% | -$58 | ﹤0.01% | 1587 |
|
|
2014
Q4 | $214K | Buy |
141,617
+113,042
| +396% | +$171K | ﹤0.01% | 1377 |
|
|
2014
Q3 | $59K | Sell |
28,575
-5,173
| -15% | -$10.7K | ﹤0.01% | 1932 |
|
|
2014
Q2 | $104K | Sell |
33,748
-4,000
| -11% | -$12.3K | ﹤0.01% | 1579 |
|
|
2014
Q1 | $94K | Buy |
37,748
+6,350
| +20% | +$15.8K | ﹤0.01% | 1544 |
|
|
2013
Q4 | $156K | Sell |
31,398
-3,400
| -10% | -$16.9K | ﹤0.01% | 1201 |
|
|
2013
Q3 | $80K | Buy |
34,798
+4,500
| +15% | +$10.3K | ﹤0.01% | 1519 |
|
|
2013
Q2 | $67K | Buy |
+30,298
| New | +$67K | ﹤0.01% | 1533 |
|
Ladenburg Thalmann Financial Services's RXII Position: Q4 2016 in Review
Ladenburg Thalmann Financial Services sold out of GALENA BIOPHARMA INC COM (RXII) in Q4 2016, closing a stake of 30,125 shares — an estimated $11K sold.
Ladenburg Thalmann Financial Services first reported a position in RXII in Q2 2013 and held it in 14 quarters. The position peaked at $261K in Q2 2015. 0 funds tracked by Wall St. Rank hold RXII as of Q4 2016.
- Ladenburg Thalmann Financial Services reported no remaining GALENA BIOPHARMA INC COM position as of Q4 2016 after selling out during the quarter.
- Ladenburg Thalmann Financial Services sold 30,125 GALENA BIOPHARMA INC COM shares in Q4 2016, an estimated $11K.
- Ladenburg Thalmann Financial Services first reported a position in GALENA BIOPHARMA INC COM in Q2 2013 and held it in 14 quarters.
- Ladenburg Thalmann Financial Services's GALENA BIOPHARMA INC COM position peaked at $261K in Q2 2015.
- 0 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q4 2016.
Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2016, filed 14 Feb 2017.